Related references
Note: Only part of the references are listed.P-selectin deficiency promotes liver senescence in sickle cell disease mice
Ravi Vats et al.
BLOOD (2021)
Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options
Chiara Agrati et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2021)
P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab
Nabin Raj Karki et al.
JOURNAL OF PAIN RESEARCH (2021)
PCN125 NOVEL ANTI-SICKLING AGENTS AND HYDROXYUREA VERSUS CHRONIC TRANSFUSIONS IN SICKLE CELL DISEASE: A COST-EFFECTIVENESS ANALYSIS
O. Onasanya et al.
VALUE IN HEALTH (2020)
Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease
Jin Han et al.
PHARMACOTHERAPY (2020)
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain
Amanda M. Brandow et al.
BLOOD ADVANCES (2020)
Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease
Kristine Karkoska et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis
Howard Thom et al.
BMJ OPEN (2020)
The Effect of Crizanlizumab on the Number of Days Requiring Opioid Use for Management of Pain Associated with Vaso-Occlusive Crises in Patients with Sickle Cell Disease: Results from the Sustain Trial
Wally R. Smith et al.
BLOOD (2020)
P-selectin-deficient mice to study pathophysiology of sickle cell disease
Margaret F. Bennewitz et al.
BLOOD ADVANCES (2020)
Vascular endothelial cell expression of JAK2(V617F) is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
Alexandre Guy et al.
HAEMATOLOGICA (2019)
P-selectin plays a role in haem-induced acute lung injury in sickle mice
Samit Ghosh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Crizanlizumab Treatment Is Associated with Clinically Significant Reductions in Hospitalization in Patients with Sickle Cell Disease: Results from the Sustain Study
Kenneth I. Ataga et al.
BLOOD (2019)
The Total Direct Cost of Healthcare in the United States in Patients with Sickle Cell Disease: A Propensity Score Matched Analysis
Jonathan Salcedo et al.
BLOOD (2019)
Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study
Nirmish Shah et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2019)
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
Abdullah Kutlar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Pathophysiology of Sickle Cell Disease
Prithu Sundd et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14 (2019)
Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies
Julie Kanter et al.
BLOOD (2019)
Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)
Bart J. Biemond et al.
BLOOD (2019)
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
Meric Ovacik et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Sickle Cell Anemia and Its Phenotypes
Thomas N. Williams et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 19 (2018)
A Phase 3 Trial of L-Glutamine in Sickle Cell Disease
Yutaka Niihara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Sickle cell disease
Gregory J. Kato et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study
Darla K. Liles et al.
BLOOD (2018)
Crizanlizumab in Sickle Cell Disease
Kenneth I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
K. I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sickle Cell Disease
Frederic B. Piel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies
Matthieu Picard et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli
Margaret F. Bennewitz et al.
JCI INSIGHT (2017)
P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1low Model of Myelofibrosis
Gerald J. Spangrude et al.
STEM CELLS (2016)
Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology
Dachuan Zhang et al.
BLOOD (2016)
Survival in adults with sickle cell disease in a high-income setting
Kate Gardner et al.
BLOOD (2016)
Cellular Adhesion and the Endothelium: P-Selectin
Abdullah Kutlar et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis
Eva Zetterberg et al.
PLATELETS (2014)
Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates
Frederic B. Piel et al.
LANCET (2013)
Stroke with intracranial stenosis is associated with increased platelet activation in sickle cell anemia
Suvankar Majumdar et al.
PEDIATRIC BLOOD & CANCER (2013)
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease
Abdullah Kutlar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Platelet-leukocyte interactions in thrombosis
Chiara Cerletti et al.
THROMBOSIS RESEARCH (2012)
Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease
Diana R. Gutsaeva et al.
BLOOD (2011)
The burden of emergency department use for sickle-cell disease: An analysis of the national emergency department sample database
Sophie Lanzkron et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Population Estimates of Sickle Cell Disease in the US
Kathryn L. Hassell
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2010)
P-Selectin-Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease
Renata Polanowska-Grabowska et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression
Elizabeth S. Klings et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Hospital readmission for adult acute sickle cell painful episodes: Frequency, etiology, and prognostic significance
SK Ballas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Endothelial cell P-selectin mediates a proinflammatory and prothrombogenic phenotype in cerebral venules of sickle cell transgenic mice
KC Wood et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm
A Turhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium
NM Matsui et al.
BLOOD (2001)
Soluble P-selectin and the risk of future cardiovascular events
PM Ridker et al.
CIRCULATION (2001)
Share Paper
